This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chinese Pla General Hospital. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Wenzhi Hu: Innovator in Exosome Technology
Introduction
Wenzhi Hu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of methods for constructing functional exosomes. His innovative work aims to enhance the efficiency of miRNA delivery for targeted regulation in therapeutic applications.
Latest Patents
Wenzhi Hu holds a patent for a method titled "Method for constructing functional exosomes capable of efficiently loading specific miRNA." This invention discloses a novel approach to enable exosomes to carry miRNA with specific regulatory functions more effectively. By utilizing MS2 phage capsid protein, he has developed a capture element for specific miRNA molecules. Additionally, he has reprogrammed placenta mesenchymal stem cells to enhance the loading of target miRNA molecules into secreted exosomes. This advancement provides a new strategy for achieving precise treatment in future medical applications.
Career Highlights
Wenzhi Hu is affiliated with the Chinese PLA General Hospital, where he continues to work on innovative solutions in biotechnology. His research focuses on the intersection of molecular biology and therapeutic applications, contributing to advancements in targeted treatments.
Collaborations
Wenzhi Hu collaborates with notable colleagues, including Qiankun Li and Cuiping Zhang. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries in the field.
Conclusion
Wenzhi Hu's contributions to exosome technology and miRNA delivery represent a significant advancement in biotechnology. His innovative methods hold promise for future therapeutic applications, paving the way for more effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile